Skip to main content
. 2023 Aug 15;25:97. doi: 10.1186/s13058-023-01692-7

Table 2.

Distributions of quantitative tissue composition metrics according to characteristics of women volunteers who donated normal breast tissue to the US-based Susan G. Komen Tissue Bank that were included in the current study (N = 4108)

Characteristic Epithelium (%) Stroma (%) Adipose tissue (%) Fibroglandular tissue (%) Epithelium-to-stroma proportion (%)
Mean Median (range) Mean Median (range) Mean Median (range) Mean Median (range) Mean Median (range)
Overall 2.1 0.89 (0.0–70.4) 24.6 17.2 (0.0–95.7) 73.3 81.0 (0.0–100.0) 26.7 18.9 (0.0–97.2) 9.2 5.9 (0.0–100.0)
Age, years
 < 30 3.0 1.46 (0.0–25.1) 35.3 29.0 (0.0–93.5) 61.8 68.0 (5.1–100.0) 38.3 32.0 (0.0–94.9) 9.0 5.6 (0.0–85.2)
30–39 2.8 1.31 (0.0–53.4) 25.9 18.7 (0.0–92.2) 71.3 79.1 (6.1–100.0) 28.7 20.9 (0.0–93.9) 10.1 7.7 (0.0–98.7)
40–49 2.2 1.02 (0.0–70.4) 22.4 16.3 (0.0–91.8) 75.4 82.3 (7.3–100.0) 24.6 17.7 (0.0–92.7) 9.8 6.6 (0.0–100.0)
50–59 1.3 0.65 (0.0–18.4) 21.0 14.7 (0.0–91.3) 77.7 84.2 (6.4–100.0) 22.3 15.8 (0.0–93.6) 8.3 5.2 (0.0–100.0)
60–75 1.0 0.49 (0.0–13.0) 17.9 11.0 (0.0–95.8) 81.1 88.4 (2.8–100.0) 18.9 11.6 (0.0–97.2) 9.0 4.7 (0.0–93.8)
P value  < 0.0001  < 0.0001  < 0.0001  < 0.0001  < 0.0001
Race/ethnicity
Non-Hispanic Caucasian 2.0 0.90 (0.0–53.4) 25.3 18.0 (0.0–95.8) 72.7 80.5 (2.8–100.0) 27.3 19.5 (0.0–97.2) 8.9 5.7 (0.0–100.0)
Black/African American 2.2 0.89 (0.0–70.4) 21.5 15.1 (0.0–88.9) 76.3 83.3 (6.1–100.0) 23.7 16.7 (0.0–93.9) 9.9 6.7 (0.0–92.2)
Asian/other 2.2 0.89 (0.0–25.1) 25.8 17.6 (0.0–91.8) 72.0 81.3 (6.1–100.0) 28.0 18.7 (0.0–93.9) 10.4 6.5 (0.0–92.9)
P value 0.98 0.02 0.08 0.08 0.01
Education
High school/GED or less 2.4 0.96 (0.0–70.4) 29.0 20.5 (0.0–93.3) 68.6 77.5 (5.1–100.0) 31.4 22.5 (0.0–94.9) 9.6 5.7 (0.0–100.0)
Vocation/tech school or associates degree 1.9 0.84 (0.0–21.3) 21.2 14.9 (0.0–95.8) 76.9 83.7 (2.8–100.0) 23.1 16.3 (0.0–97.2) 9.2 6.6 (0.0–100.0)
College degree 2.1 0.94 (0.0–26.6) 35.6 18.6 (0.0–92.7) 72.3 79.9 (5.7–100.0) 27.7 20.1 (0.0–94.3) 9.0 5.8 (0.0–93.7)
Graduate/professional degree 2.1 0.87 (0.0–53.4) 23.2 16.1 (0.0–93.1) 74.7 82.8 (6.4–100.0) 25.3 17.2 (0.0–93.6) 9.6 6.0 (0.0–98.7)
Other 1.9 0.85 (0.0–17.6) 24.0 17.3 (0.0–93.5) 74.1 80.8 (5.6–100.0) 25.9 19.2 (0.0–94.4) 8.5 5.7 (0.0–87.1)
P value 0.58  < 0.0001  < 0.0001  < 0.0001 0.34
Smoking
Never 2.2 0.95 (0.0–53.4) 25.1 18.1 (0.0–95.8) 72.7 80.4 (2.8–100.0) 27.3 19.6 (0.0–97.2) 9.1 6.0 (0.0–100.0)
Former 1.6 0.72 (0.0–70.4) 22.9 15.7 (0.0–92.1) 75.5 83.3 (6.3–100.0) 24.5 16.7 (0.0–93.7) 9.0 5.3 (0.0–100.0)
Current 1.9 0.96 (0.0–9.76) 27.7 22.1 (0.0–92.5) 70.4 77.0 (5.7–100.0) 29.6 23.0 (0.0–94.8) 10.0 6.1 (0.0–93.7)
P value 0.008 0.13 0.02 0.02 0.03
Currently drink alcohol
No 2.0 0.86 (0.0–70.4) 23.1 15.3 (0.0–95.8) 74.8 83.2 (2.8–100.0) 25.2 16.8 (0.0–97.2) 9.6 6.3 (0.0–100.0)
Yes 2.1 0.92 (0.0–53.4) 25.4 18.4 (0.0–93.1) 72.5 80.2 (5.1–100.0) 27.5 19.8 (0.0–94.9) 9.0 5.8 (0.0–100.0)
P value 0.73 0.02 0.69 0.03 0.06
Average number of alcoholic drinks per week
 < 1 2.0 0.84 (0.0–23.3) 22.9 13.8 (0.0–84.6) 75.1 84.1 (10.5–100.0) 24.9 15.9 (0.0–89.5) 10.9 7.0 (0.2–93.7)
1–6 2.2 0.91 (0.0–53.4) 25.6 18.8 (0.0–93.1) 72.2 79.1 (5.1–100.0) 27.8 20.3 (0.0–95.9) 8.8 5.6 (0.0–100.0)
 ≥ 7 1.7 0.92 (0.0–15.4) 26.8 18.7 (0.0–91.9) 71.5 69.9 (6.9–100.0) 28.5 20.1 (0.0–93.0) 7.2 4.7 (0.0–62.4)
P value 0.69 0.003 0.006 0.006  < 0.0001
Body mass index
 < 25 2.6 1.25 (0.0–53.4) 32.4 26.1 (0.0–95.8) 65.0 71.9 (2.8–100.0) 35.0 28.1 (0.0–97.2) 8.0 5.1 (0.0–98.7)
25–29 1.9 0.79 (0.0–36.2) 23.6 15.8 (0.0–93.5) 74.5 82.4 (5.6–100.0) 25.5 17.6 (0.0–94.4) 9.2 5.9 (0.0–100.0)
 ≥ 30 1.8 0.74 (0.0–70.4) 19.5 12.9 (0.0–92.4) 78.7 85.6 (6.1–100.0) 21.3 14.4 (0.0–93.9) 1.0 6.9 (0.0–97.5)
P value  < 0.0001  < 0.0001  < 0.0001  < 0.0001  < 0.0001
Age at menarche, years
 ≤ 12 2.1 0.89 (0.0–70.4) 23.5 16.1 (0.0–92.7) 74.4 82.4 (5.1–100.0) 25.6 17.6 (0.0–94.9) 9.5 6.3 (0.0–100.0)
13 2.1 0.95 (0.0–53.4) 25.7 18.2 (0.0–95.8) 72.1 80.3 (2.8–100.0) 27.9 19.7 (0.0–97.2) 8.9 5.4 (0.0–89.7)
 ≥ 14 2.0 0.86 (0.0–24.9) 26.2 19.2 (0.0–93.1) 71.9 79.2 (5.2–100.0) 28.1 20.8 (0.0–94.8) 9.0 5.6 (0.0–100.0)
P value 0.54 0.009 0.01 0.01 0.002
Current hormonal birth control use
No 2.6 1.18 (0.0–70.4) 27.3 19.9 (0.0–93.5) 70.1 77.8 (5.1–100.0) 29.9 22.2 (0.0–94.9) 9.6 6.5 (0.0–100.0)
Yes 2.7 1.48 (0.0–24.7) 29.2 21.2 (0.0–92.7) 68.2 76.4 (6.3–99.9) 27.0 23.6 (0.0–93.7) 9.7 6.8 (0.0–85.2)
P value 0.10 0.29 0.28 0.28 0.29
Parity
Nulliparous 2.2 0.88 (0.0–25.1) 27.9 18.9 (0.0–93.5) 70.0 79.4 (5.1–100.0) 30.0 20.6 (0.0–94.9) 8.9 5.3 (0.0–100.0)
Parous 2.1 0.91 (0.0–70.4) 23.2 16.6 (0.0–95.8) 74.8 81.8 (2.8–100.0) 25.2 18.2 (0.0–97.2) 9.4 6.3 (0.0–100.0)
P value 0.44 0.13 0.06 0.06  < 0.0001
Number of live births
0 1.9 0.74 (0.0–21.3) 26.8 21.2 (0.02–87.5) 71.3 76.7 (9.1–100.0) 28.7 23.3 (0.0–90.9) 7.6 5.3 (0.0–51.1)
1 1.8 0.91 (0.0–26.6) 23.4 16.8 (0.0–89.7) 74.8 81.8 (6.1–100.0) 25.2 18.2 (0.0–93.9) 8.9 5.8 (0.0–97.5)
2 2.1 0.98 (0.0–36.2) 22.7 15.6 (0.0–91.3) 75.2 82.5 (6.4–100.0) 24.8 17.5 (0.0 93.6) 9.8 6.7 (0.0–100.0)
 ≥ 3 2.1 0.87 (0.0–70.4) 21.1 15.0 (0.0–95.8) 76.9 83.6 (2.8–100.0) 23.1 16.4 (0.0–97.2) 10.1 6.9 (0.0–82.5)
P value 0.69  < 0.0001 0.0003 0.0003  < 0.0001
Age at first full-term birth, years
 < 25 2.0 0.83 (0.0–26.6) 21.6 15.0 (0.0–95.8) 76.4 84.1 (2.8–100.0) 23.6 15.9 (0.0–97.2) 8.7 6.3 (0.0–88.0)
25–29 2.1 1.06 (0.0–53.4) 23.4 18.7 (0.0–85.9) 74.4 79.9 (7.7–100.0) 25.6 20.1 (0.0–92.2) 8.9 5.9 (0.0–100.0)
 ≥ 30 2.1 1.08 (0.0–36.2) 23.4 17.2 (0.0–91.3) 74.5 81.2 (6.4–100.0) 25.5 18.8 (0.0–93.6) 9.1 5.7 (0.0–68.6)
P value 0.35 0.38 0.3612 0.36 0.0038
Breastfeeding
Never 1.6 0.68 (0.0–70.4) 20.2 13.5 (0.0–95.8) 78.2 85.6 (2.8–100.0) 21.8 14.4 (0.0–97.2) 9.8 6.2 (0.0–97.5)
Ever 2.2 1.05 (0.0–53.4) 23.5 17.5 (0.0–91.3) 74.3 80.9 (6.1–100.0) 25.7 19.1 (0.0–93.9) 9.5 6.6 (0.0–100.0)
P value 0.0002  < 0.0001  < 0.0001  < 0.0001 0.0002
Breastfeeding duration, months
Never 1.6 0.7 (0.0–70.4) 20.2 13.5 (0.0–95.8) 78.2 85.6 (2.8–100.0) 21.8 14.4 (0.0–97.2) 9.8 6.2 (0.0–97.5)
 < 12 2.1 1.04 (0.0–26.6) 23.2 18.0 (0.0–91.3) 74.7 80.5 (6.1–100.0) 25.3 19.5 (0.0–93.9) 9.4 6.5 (0.0–100.0)
 ≥ 12– < 24 2.2 1.02 (0.0–36.2) 23.9 16.2 (0.0–89.3) 73.9 82.3 (8.6–100.0) 26.1 17.7 (0.0–91.4) 9.2 6.6 (0.0–65.9)
 ≥ 24 2.5 1.15 (0.0–53.4) 23.8 17.0 (0.0–90.5) 73.7 81.0 (7.7–100.0) 26.3 19.0 (0.0–92.2) 10.1 7.0 (0.0–91.0)
P value 0.0016  < 0.0001  < 0.0001  < 0.0001 0.002
Bilateral oophorectomy
No 1.2 0.60 (0.0–18.4) 20.5 13.9 (0.0–90.6) 78.3 85.2 (9.2–100.0) 21.7 14.8 (0.0–90.8) 8.5 5.2 (0.0–93.7)
Yes 1.0 0.47 (0.0–12.0) 17.5 11.6 (0.0–79.3) 81.8 87.6 (20.4–100.0) 18.2 12.4 (0.0–79.6) 8.5 4.7 (0. 0–97.5)
P value 0.01 0.02 0.02 0.02 0.12
Menopausal status
Premenopausal 2.6 1.26 (0.0–70.4) 28.1 20.6 (0.0–93.5) 69.3 77.1 (5.1–100.0) 30.7 22.9 (0.0–94.9) 9.7 6.6 (0.0–100.0)
Postmenopausal 1.2 0.56 (0.0–21.3) 19.1 12.6 (0.0–95.8) 79.7 86.2 (2.8–100.0) 20.3 13.8 (0.0–97.2) 8.4 5.0 (0.0–100.0)
Uterine Ablation 2.3 1.07 (0.0–18.4) 25.7 20.6 (0.0–89.9) 72.0 77.5 (7.8–80.5) 28.0 22.5 (0.0–92.1) 10.2 7.6 (0.12–74.0)
P value  < 0.0001  < 0.0001  < 0.0001  < 0.0001  < 0.0001
Menopausal hormone therapy
Nonuser 1.2 0.53 (0.0–18.4) 18.6 12.7 (0.0–91.3) 80.2 86.2 (6.4–100.0) 19.8 13.8 (0.0–93.6) 8.8 5.2 (0.0–100.0)
Current user 0.8 0.45 (0.0 10.0) 20.3 12.2 (0.0–95.8) 78.9 87.2 (2.7–100.0) 21.1 12.8 (0.0–97.2) 6.2 3.1 (0.0–87.1)
Former user 1.4 0.52 (0.0–13.0) 19.9 15.3 (0.0–90.6) 78.7 83.5 (9.3–100.0) 21.3 16.5 (0.0–90.7) 8.0 5.3 (0.0–55.9)
P value 0.0006 0.63 0.67 0.67  < 0.0001
Menopausal hormone therapy type-current user
Nonuser 1.2 0.53 (0.0–18.4) 18.6 12.6 (0.0–91.3) 80.3 86.2 (6.4–100.0) 19.7 13.8 (0.0–93.6) 8.8 5.1 (0.0–100.0)
Estrogen only 0.8 0.60 (0.0–5.2) 17.8 11.0 (0.0–71.6) 81.4 88.7 (25.1–100.0) 18.6 11.3 (0.0–74.9) 6.5 4.0 (0.0–87.1)
Combined estrogen and progesterone 0.8 0.32 (0.0–9.1) 22.9 14.7 (0.1–86.7) 76.3 85.1 (12.2–99.9) 23.7 14.9 (0.1–87.8) 6.3 2.5 (0.0–57.6)
P value 0.04 0.54 0.61 0.61  < 0.0001
Menopausal hormone therapy type-former user
Nonuser 1.2 0.53 (0.0–18.4) 18.6 12.6 (0.0–91.3) 80.3 86.2 (6.4–100.0) 19.7 13.8 (0.0–93.6) 8.8 5.1 (0.0–100.0)
Estrogen only 1.2 0.60 (0.0–6.3) 19.4 15.8 (0.02–68.4) 79.5 83.3 (30.5–100.0) 20.5 16.7 (0.0–69.5) 8.0 5.5 (0.0–42.7)
Combined estrogen and progesterone 1.2 0.51 (0.0–6.2) 21.0 9.8 (0.0–90.6) 77.8 89.7 (9.3–100.0) 22.2 10.3 (0.0–90.7) 6.8 4.2 (0.0–55.9)
P value 0.68 0.76 0.77 0.77 0.33
Family history of breast cancer
Negative 2.1 0.92 (0.0–53.4) 25.4 18.0 (0.0–95.8) 72.5 80.5 (2.8–100.0) 27.5 19.5 (0.0–97.2) 9.1 5.8 (0.0–100.0)
Positive 1.9 0.78 (0.0–70.4) 22.0 15.3 (0.0–93.3) 76.0 83.0 (5.3–100.0) 24.0 17.0 (0.0–94.7) 9.7 6. 2 (0.0–92.9)
P value 0.40 0.002 0.003 0.003 0.06

Asian/Other category comprised women who self-identified as Asian, Chinese, Filipino, Japanese, “Other” Asian, Asian/Native Hawaiian or Pacific Islander, etc. Parity: parous = women who had previously been pregnant, irrespective of the outcome; nulliparous = women who had never been pregnant. NLB = Number of Live Births (0 = previous pregnancies did not result in a live birth). P values were obtained using Kruskal–Wallis’s test. P values <0.05 were considered statistically significant and are indicated using bold fonts